UK to roll out Covid-19 booster jabs for over-50s from next week

British government will be accepting an expert panel's recommendation and begin the rollout of booster vaccine shots across England for over-50s from next week, UK Health Secretary told Parliament

Coronavirus, vaccine, covid-19, vaccination
Press Trust of India London
3 min read Last Updated : Sep 14 2021 | 7:21 PM IST

The British government will be accepting an expert panel's recommendation and begin the rollout of booster vaccine shots across England for over-50s from next week, UK Health Secretary Sajid Javid told Parliament on Tuesday.

Tabling the government's winter strategy to tackle COVID-19, Javid told the House of Commons that the National Health Service (NHS) in England is preparing for the rollout following the Joint Committee on Vaccination and Immunisation's (JCVI) recommendation earlier.

Wales has also accepted the JCVI advice, with other devolved regions of the UK Scotland and Northern Ireland also expected to follow.

"I can confirm that I have accepted the JCVI's advice and that the NHS is preparing to offer booster doses from next week," said Javid.

"There's evidence that the protection offered by COVID-19 vaccines reduces over time, particularly older people who are at greater risk, so booster doses are an important way of keeping the virus under control for the long-term, he said.

Among the other announcements for the government's winter strategy of "living with the virus" without the need to resort to further full lockdowns, Javid also outlined a Plan B of contingency measures, including working from home and face coverings.

"We have seen how quickly this virus can adapt and change so we have prepared a Plan B of contingency measures that we can call upon only if they are needed and supported by the data to prevent unsustainable pressure on the NHS, he said.

"These measures would be communicating clearly and urgently the need for caution. Legally mandating face coverings in certain settings, he added.

Earlier, the UK's expert advisory panel on vaccines recommended that a third booster dose of a COVID-19 vaccine would be beneficial for people aged over 50 and frontline healthcare workers to boost their protection against the deadly virus over the winter months.

The Joint Committee on Vaccination and Immunisation's (JCVI) recommendation notes that six months after a second COVID vaccine dose is the optimum timing to boost immunity with another dose, with the Pfizer/BioNTech or Moderna vaccines among those ideal for use as a third jab.

"Getting a dose too early may mean they do not need it as they still have a high level of protection, and as we've seen with the gap between the first and second dose, you don't want to have it too early," JCVI Chair Professor Wei Shen Lim told reporters at a briefing on Tuesday.

He also indicated a recurrent booster every six months may not be needed but it is too early to be sure about that.

England's Deputy Chief Medical Officer Professor Jonathan Van-Tam said following the JCVI decision, he expects the boosters to be offered "within days" and they will be taking place at mass vaccination centres and GPs.

Van-Tam warned of a "bumpy" winter ahead despite the vaccines having been "incredibly successful" and had so far prevented an estimated 24 million COVID-19 cases and 112,000 deaths.

"But we also know that this pandemic is still active. We are not past the pandemic, we are in an active phase still," he said.

"We know that this winter could quite possibly be bumpy at times and we know that other respiratory viruses such as flu and RSV are highly likely to make their returns," he added.

The JCVI briefing comes ahead of a government statement laying out its winter strategy for tackling COVID-19 without having to resort to further lockdowns.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :CoronavirusCoronavirus VaccineUK

First Published: Sep 14 2021 | 7:21 PM IST

Next Story